Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine plus thiopental versus dexmedetomidine plus ketamine for ECT anesthesia
IRCT20141209020258N81Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in mental disorder comparing Dexmedetomidine + thiopental with Dexmedetomidine + ketamine (2 arms). Primary endpoints: Duration of recovery, Seizure duration and 6 more. Started Nov 2017; status: completed.
02
Drugs
dexmedetomidinethiopentalketamine
03
Conditions
mental disorder
Beyond the preview
Go deeper on IRCT20141209020258N81.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141209020258N81.